Gut microbiome analysis firm DayTwo will collaborate with Johnson & Johnson on personalised clinical nutrition for diabetes, and plans to open up its nutrition recommendation platform to new partners.
Norwegian krill player Aker BioMarine has commissioned a new environmentally-friendly krill fishing vessel, at a cost of around €112.6 million (NOK 1 billion).
EU health claim specialists say EFSA guidance issued last week clarifies application procedures but changes nothing of the infamous pharma-style scientific requirements that have denied 1000s of claims across the EU bloc of 28 nations.
The use of supplemental vitamin C after heart surgery could help to lower risks of atrial fibrillation, a common disturbance in heart rhythms, in addition to shortening overall time in hospital, finds a new meta-analysis.
Reckitt Benckiser Group plc (RB) has confirmed it is in ‘advanced negotiations’ to acquire all Mead Johnson Nutrition shares for $90 each in cash, valuing Mead Johnson’s entire share capital at approximately $16.7bn.
EFSA has called for further studies into the safety of locust bean gum for specialised infant and baby nutrition products, as it also opens a consultation into infant formulae from protein hydrolysates.
A range of high fibre and high protein ice creams that have better tastes and textures than standard hospital food will soon be on the menu for patients.
Personalised nutrition is emerging fast – as technologies like gene mapping and smartphones offer the potential for people to optimise nutrition, live healthier lives and reduce the burden of chronic disease like obesity and diabetes.
Firm open to more M&A activity after profits more than double
Swedish probiotic player Probi could soon re-submit an EFSA dossier for iron uptake, says CEO Peter Nählstedt as he talks to NutraIngredients about how the company more than doubled its profits in 2016.
From shots, to sweets, pills and bars; nutrients and functional ingredients can be delivered in a variety of ways. But can the nutrition industry learn a thing or three from how pharmaceutical companies are improving ingredient delivery and bioavailability?
Ingredients giant BASF will collaborate with Irish start-up Nuritas on the discovery and commercialisation of novel functional peptides using DNA analysis and artificial intelligence (AI).
